Dapzura Rt Injection, Powder, Lyophilized, For Solution
Product Images NDC 60977-145

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Dapzura Rt (NDC 60977-145). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Baxter Healthcare Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Daptomycin Structural Formula (Image 01)

Daptomycin Structural Formula (Image 01)
Chemical structure of daptomycin, the active ingredient in DAPZURA RT injection, powder, lyophilized, for solution available in 500 mg strength.*
FDA Label Image

Daptomycin Representative Container Label 60977-145-01 (Image 02)

Daptomycin Representative Container Label  60977-145-01 (Image 02)
DAPZURA RT (daptomycin for injection) 500 mg per vial, lyophilized powder for intravenous injection, from Baxter Healthcare Corporation. The label includes storage instructions (store at 20°C to 25°C), reconstitution with 10 mL sterile or bacteriostatic water, and usage notes for single-dose vial with discard of unused portion.*
FDA Label Image

Daptomycin Representative Carton Label 60977-145-01 (Image 03 1 Of 2)

Daptomycin Representative Carton Label  60977-145-01 (Image 03 1 Of 2)
Package label for DAPZURA RT (daptomycin for injection) 500 mg per vial, lyophilized powder for intravenous injection. The label includes dosage instructions, storage conditions, and specifies the use of sterile water or bacteriostatic water for reconstitution. Manufactured by Baxter Healthcare Corporation.*
FDA Label Image

Image 04 2 Of 2

Image 04 2 Of 2
Label for DAPZURA RT (daptomycin for injection) 500 mg per vial, lyophilized powder for intravenous use. Instructions include reconstituting the vial with 10 mL Sterile Water for Injection or Bacteriostatic Water for Injection to achieve 50 mg/mL concentration. The label also notes excipient contents, storage instructions, single-dose use, and is labeled Rx only. The product is by Baxter Healthcare Corporation.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.